In the US, Felbamate (felbamate systemic) is a member of the drug class carbamate anticonvulsants and is used to treat Epilepsy and Lennox-Gastaut Syndrome.
US matches:
- Felbamate
- Felbamate Suspension
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N03AX10
CAS registry number (Chemical Abstracts Service)
0025451-15-4
Chemical Formula
C11-H14-N2-O4
Molecular Weight
238
Therapeutic Category
Antiepileptic agent
Chemical Name
2-Phenyl-1,3-propanediol dicarbamate
Foreign Names
- Felbamatum (Latin)
- Felbamat (German)
- Felbamate (French)
- Felbamato (Spanish)
Generic Names
- Felbamate (OS: USAN, DCF)
- AD 03055 (IS)
- W 554 (IS: Wallace)
Brand Names
- Felbamyl
Schering-Plough, Argentina - Felbatol
Meda, United States - Taloxa
Aesca, Austria; Essex, Germany; Essex Chemie, Switzerland; Schering-Plough, Belgium; Schering-Plough, France; Schering-Plough, Hungary; Schering-Plough, Italy; Schering-Plough, Luxembourg; Schering-Plough, Netherlands; Schering-Plough, Norway; Schering-Plough, Portugal; Schering-Plough, Sweden
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment